Familial Danish dementia

From Wikipedia, the free encyclopedia
Familial Danish dementia
Other names
  • FDD
  • Heredopathia ophthalmootoencephalica
  • HOOE
  • ITM2B amyloidosis
  • Cerebellar ataxia, cataract, deafness, and dementia or psychosis[1]
Symptoms
Usual onset30 years old[3]

Familial Danish Dementia is a rare neurodegenerative disease that is mostly hereditary[4] and resembles Alzheimer's.[5] The condition was first reported in the Djürsland peninsula in Denmark.[6]: 163 

It is one of the two types of hereditary cerebral amyloid angiopathy alongside familial British dementia.[7]

The disorder is histopathologically characterized by serve cerebral amyloid angiopathy with neurofibrillary tangle deposition in the limbic system and the neocortex.[8] It is also neuropathologically characterized by diffuse atrophy of cerebellum, cranial nerves, and the spinal cord.[9]

Prognosis[]

Most people with this condition die when they reach their fifties or sixties,[4] with the median age of death being 58.[10] They usually die due to complications from pneumonia, diarrhea, and strokes.[11]

Diagnosis[]

The condition resembles Begger syndrome and Refsum disease.[11]

Epidemiology[]

Familial Danish Dementia has been reported in a single family spanning three generations,[12] with there being nine reported cases as of 2014.[6] Males and females are equally affect by the disorder.[10]

Causes[]

The disorder is caused by autosomal mutations that are inherited.[13]

Such as a mutation in the BRI2 gene on chromosome 13.[14] It is also said to be caused by mutations in CHMP2B.[15]

Mutations in cystatin c have also been suggested to be a cause of the disorder.[16]

Symptoms[]

Symptoms like cataracts, deafness, or ataxia appear before age 40.[12]

Cerebellar ataxias appears around age 40.[6]

There is also paranoid psychosis and dementia.[12] Which both occur when the patient reaches their fifties.[17] Although paranoid psychosis which typically develops after age 50.[18]

Hearing impairments[]

Hearing loss can appear around 40s to 50s.[17] Hearing impairments can also appear as young as age 10 to 20.[19] Severe hearing loss can occur around age 45.[11]

Visual symptoms[]

Vision problems are one the earliest symptoms of FDD with cataracts usually appear before age 30.[10] The development of cataracts can appear as early as age 20.[6] The median age for visual symptoms is 27.[10]

Other symptoms[]

Other symptoms include intention tremor, neurofibrillary tangles, spasticity,[20] apathy, , early dyscalculia, and stereotyped behavior.[15]

Cerebral amyloid angiopathy in this disorder is severe.[21] CAA is present in all regions of the central nervous system.[22]

References[]

  1. ^ "Dementia, familial Danish | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
  2. ^ Paul, Robert H. (2007-11-17). Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management. Springer Science & Business Media. p. 42. ISBN 978-1-59259-824-3.
  3. ^ Sharma, Pankaj; Meschia, James F. (2012-08-27). Stroke Genetics. Springer Science & Business Media. p. 75. ISBN 978-0-85729-209-4.
  4. ^ a b Holton, Janice L.; Lashley, Tammaryn; Ghiso, Jorge; Braendgaard, Hans; Vidal, Ruben; Guerin, Christopher J.; Gibb, Graham; Hanger, Diane P.; Rostagno, Agueda; Anderton, Brian H.; Strand, Catherine (March 2002). "Familial Danish Dementia: A Novel Form of Cerebral Amyloidosis Associated with Deposition of Both Amyloid-Dan and Amyloid-Beta". Journal of Neuropathology & Experimental Neurology. 61 (3): 254–267. doi:10.1093/jnen/61.3.254. ISSN 0022-3069. PMID 11895040.
  5. ^ Husain, Masud; Schott, Jonathan M. (2016). Oxford Textbook of Cognitive Neurology and Dementia. Oxford University Press. p. 317. ISBN 978-0-19-965594-6.
  6. ^ a b c d Encyclopedia of the Neurological Sciences. Academic Press. 2014-04-29. pp. 163–164. ISBN 978-0-12-385158-1.
  7. ^ "Hereditary cerebral amyloid angiopathy: MedlinePlus Genetics". medlineplus.gov. Retrieved 2021-09-07.
  8. ^ MD, Thomas P. Naidich; MD, Mauricio Castillo; MD, Soonmee Cha; MD, James G. Smirniotopoulos (2012-10-31). Imaging of the Brain: Expert Radiology Series. Elsevier Health Sciences. ISBN 978-1-4160-5009-4.
  9. ^ Pantoni, Leonardo; Gorelick, Philip B. (May 2014). Cerebral Small Vessel Disease. Cambridge University Press. p. 87. ISBN 978-1-107-03166-1.
  10. ^ a b c d Dickson, Dennis; Weller, Roy O. (2011-09-09). Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. John Wiley & Sons. p. 440. ISBN 978-1-4443-4123-2.
  11. ^ a b c Toriello, Helga V.; Smith, Shelley D. (2013-08-08). Hereditary Hearing Loss and Its Syndromes. OUP USA. p. 489. ISBN 978-0-19-973196-1.
  12. ^ a b c Wahlund, Lars-Olof; Erkinjuntti, Timo; Gauthier, Serge (2009-02-12). Vascular Cognitive Impairment in Clinical Practice. Cambridge University Press. p. 150. ISBN 978-0-521-87537-0.
  13. ^ Amyloidosis: New Insights for the Healthcare Professional: 2012 Edition: ScholarlyBrief. ScholarlyEditions. 2012-12-10. p. 4. ISBN 978-1-4649-7441-0.
  14. ^ Kovacs, Gabor G. (2014-12-04). Neuropathology of Neurodegenerative Diseases Book and Online. Cambridge University Press. p. 254. ISBN 978-1-107-44242-9.
  15. ^ a b Husain, Masud; Schott, Jonathan M. (2016). Oxford Textbook of Cognitive Neurology and Dementia. Oxford University Press. pp. 347–348. ISBN 978-0-19-965594-6.
  16. ^ Picken, Maria M.; Herrera, Guillermo A.; Dogan, Ahmet (2015-08-17). Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations. Humana Press. p. 126. ISBN 978-3-319-19294-9.
  17. ^ a b Larner, Andrew J.; Coles, Alasdair J.; Scolding, Neil J.; Barker, Roger A. (2011-01-19). A-Z of Neurological Practice: A Guide to Clinical Neurology. Springer Science & Business Media. pp. 257–258. ISBN 978-1-84882-994-7.
  18. ^ Holton, Janice L.; Lashley, Tammaryn; Ghiso, Jorge; Braendgaard, Hans; Vidal, Ruben; Guerin, Christopher J.; Gibb, Graham; Hanger, Diane P.; Rostagno, Agueda; Anderton, Brian H.; Strand, Catherine (March 2002). "Familial Danish Dementia: A Novel Form of Cerebral Amyloidosis Associated with Deposition of Both Amyloid-Dan and Amyloid-Beta". Journal of Neuropathology & Experimental Neurology. 61 (3): 254–267. doi:10.1093/jnen/61.3.254. ISSN 0022-3069. PMID 11895040.
  19. ^ Kovacs, Gabor G. (2014-12-04). Neuropathology of Neurodegenerative Diseases Book and Online. Cambridge University Press. p. 255. ISBN 978-1-107-44242-9.
  20. ^ "Dementia, familial Danish | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2021-09-07.
  21. ^ Love, Seth; Louis, David; Ellison, David W. (2008-02-29). Greenfield's Neuropathology Eighth Edition 2-Volume Set. CRC Press. p. 1115. ISBN 978-1-4665-8543-0.
  22. ^ Clark, Leon V. (2004). Trends in Atherosclerosis Research. Nova Publishers. p. 198. ISBN 978-1-59454-046-2.
Retrieved from ""